Complementary Dual Approach for In Silico Target Identification of Potential Pharmaceutical Compounds in Cystic...

Area of Science:

• Biochemistry
• Genetics
• Systems Biology

Background:

• Cystic fibrosis (CF) is a genetic disorder caused by mutations in the CFTR gene, impacting epithelial cell function.
• Developing effective treatments for CF is challenging due to diverse patient phenotypes.
• While small-molecule drugs have emerged, understanding their mechanisms of action is crucial for discovering novel therapeutics.

Purpose of the Study:

• To identify the molecular targets of active compounds relevant to cystic fibrosis.
• To integrate a CFTR-specific compound database with a systems biology model for drug discovery.
• To systematically predict potential drug-target interactions for novel CFTR therapeutics.

Main Methods:

• Developed and utilized a CFTR-specific compound database (CandActCFTR).
• Employed a systems biology model, the CFTR Lifecycle Map, comprising 90 protein targets.
• Applied a dual inverse screening approach combining target- and ligand-based methods.

Main Results:

• Identified 1038 potential target-compound pairings.
• Successfully suggested targets for all 309 active compounds within the CandActCFTR database.
• Provided a comprehensive resource for understanding compound mechanisms in CFTR research.

Conclusions:

• The integrated approach effectively predicts drug targets for CFTR-related compounds.
• This methodology accelerates the identification of novel therapeutic candidates for cystic fibrosis.
• The study provides a foundation for further investigation into compound mechanisms and drug development for CF.